drugset / Trial / NCT00673790
The Blood Pressure and Metabolic Effects of Nebivolol in Hypertensive Patients With Impaired Glucose Tolerance or Impaired Fasting Glucose
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is being done to see if the blood pressure and metabolic effects of an approved drug nebivolol is comparable to that of another approved drug hydrochlorothiazide (HCTZ) and placebo in hypertensive patients.
Timeline
- Start
- 2008-05-15
- Primary completion
- 2010-07-09
- Completion
- 2010-07-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrochlorothiazide | Unknown | 12.5 mg | Oral |
| Comparator | Hydrochlorothiazide | Unknown | 25 mg | Oral |
| Comparator | Nebivolol | Other / unclassified | 5 mg | Oral |
| Comparator | Nebivolol | Other / unclassified | 10 mg | Oral |
| Comparator | Nebivolol | Other / unclassified | 20 mg | Oral |
| Comparator | Nebivolol | Other / unclassified | 40 mg | Oral |
| Comparator | LISINOPRIL ANHYDROUS | Small molecule | 10 mg | Oral |
| Comparator | Losartan | Other / unclassified | 50 mg | Oral |